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TB vaccinesObjective/background: There is an urgent need for a more effective vaccine against Mycobac-
terium tuberculosis (Mtb). Although CD4+ T cells play a central role in host immunity to Mtb,
recent evidence suggests a critical role of CD8+ T cells in combating Mtb. In the present
study, we have predicted HLA antigen class I binding peptides of DosR operon using an
in-silico approach. This method is useful as an initial computational filtration of probable
epitopes based on their binding ability and antigenicity.
Methods: CD8+ epitopes were predicted by software NetMHC 3.4 and BIMAS. Self-peptides
were found and excluded by indigenously developed Perl script. Antigenicity of promiscu-
ous peptides was predicted using a VaxiJen server. The top VaxiJen scoring antigenic pep-
tides were docked to globally relevant HLA allele using CABS dock and Hex program.
Results: A total of 1436 overlapping nonamer peptides were generated which gave 46
promiscuous epitopes, 25 were predicted to be antigenic. Rv2627 epitope ‘‘SAFRPPLV”which
gave the highest Vaxijen score of 1.9157 and showed binding to all the three HLA loci. The
top VaxiJen scoring antigenic peptides were docked and had significant interactions with
residues of the HLA class I molecule indicating them to be good cytotoxic T lymphocyte epi-
topes.
Conclusion: Our study has generated several promiscuous antigenic peptides capable of
binding to major histocompatibility complex class I with high affinity. These epitopes
can become part of a postexposure multivalent subunit vaccine upon experimental
validation.
 2015 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.10936017.
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Tuberculosis (TB) is a major infectious disease of global con-
cern, which has afflicted humans throughout the recorded
history [1,2]. The World Health Organization ranks TB among
the top 10 causes of human mortality in the world.
To protect against TB, vaccination with the attenuated
Mycobacterium bovis Bacillus Calmette–Gue´rin (BCG) has been
practiced worldwide for several decades. However, BCG vacci-
nation has shown highly variable efficacy to protect against
the most infectious form of disease in adults, that is,
pulmonary TB [3,4]. In addition, the diagnostic value of the
present skin test reagent purified protein derivative of
Mycobacterium tuberculosis (Mtb) is not very reliable because
of antigens that are cross-reactive with environmental
mycobacteria and the vaccine strains of M. bovis present in
BCG. Furthermore, BCG being a live attenuated vaccine can
become virulent and cause disease in immune compromised
individuals, such as AIDS patients [3]. Hence, identification of
antigens that are useful for the specific diagnosis and devel-
opment of improved vaccines with respect to greater safety
and protective efficacy globally is an urgent need [4].
Mtb is an intracellular pathogen, against which a cell
mediated immune response whether a CD4 or CD8 is
mounted. Response of a T-cell is dependent upon the process-
ing of the antigen into 8–15 amino acid long peptides. These
peptides then interact with the major histocompatibility
complex (MHC). Different peptides bind to the MHC molecule
with different affinity and off-rate (the duration of peptide
binding to the MHC molecule) [5]. The last step is recognition
of this tri-molecular complex of MHC–b2 microglobulin–pep-
tide by T cells. Two factors play a decisive role when an anti-
gen is presented by MHC molecules: (1) the nature of the
presenting MHC allele; and (2) the amino acid (AA) composi-
tion of the target peptide.
In the past, the focus of vaccine development has been on
early phase proteins like Ag85, ESAT-6, CFP-10, and so forth,
expressed during the initial phase of Mtb infection. However,
Mtb late phase proteins like Dormancy Survival Regulon
(DosR) proteins that are expressed under intracellular adverse
conditions have also been shown to induce a strong T cell and
interferon-c response and, therefore, could prove to be good
vaccine candidates [3,6–11]. In our previous study, several
DosR regulon latency antigens were shortlisted as good vac-
cine candidates [3]. Some of these proteins show a good
CD8 cell response in our laboratory (unpublished data),
wherein Rv2627 elicited highest response. In the present
study, we wish to bioinformatically identify promiscuous
antigenic CD8+ cell epitopes derived from the six selected
DosR proteins. The identified epitopes may then be included
in an epitope-bound vaccine design.
Althoughmainly CD4+ Th1 cells elicit a protective immune
response against Mtb, experimental evidence also suggests a
role for CD8+ T cells in both active and latent TB [12,13]. Mice
studies involving adoptive transfer of CD8+ T or their in vivo
depletion have shown that this subset could confer protection
against subsequent challenge of Mtb [14]. Mice deficient in
components of MHC class I were also found to be more sus-
ceptible to the infection [15]. Caccamo et al [13] have shownthat healthy people with latent TB infection have a high fre-
quency of Mtb antigen specific CD8+ T cells, thus, showing
a protective and long lived immune response [13]. Therefore,
it is worth investigating important CD8+ T cell epitopes that
help mount a cellular immune response against infected
macrophages.
Materials and methods
Prediction of physiochemical properties
The complete AA sequences of the six proteins Rv2029,
Rv2031, Rv2032, Rv2626, Rv2627, and Rv2628 of Mtb were
obtained from the TubercuList database [16]. The six proteins
were analyzed for their subcellular localization with the
PsortB software [17]. The transmembrane region was
predicted using TMHMM and HMMTOP [18,19]. The presence
of a signal sequence was predicted using the SignalP software
[20].
Prediction of CD8 epitopes
The selected DosR protein sequences were passed through
two software servers, BIMAS and NetMHC 3.4, which generate
overlapping epitopes by a step size of one residue. The length
of the epitopes was selected to be nine AA MHC class I prefer-
entially bind nonamers.
BIMAS uses HLA BIND prediction algorithm and estimates
the binding against nine HLA-A alleles, 20 HLA-B alleles, and
four HLA-C alleles. For BIMAS a T1/2 of 100 min was chosen as
a cut-off point in order to select the relatively high-affinity
binding peptides [21,22].
NetMHC Server predicts epitopes for 34 alleles of HLA-A,
33 alleles of HLA-B, and 10 alleles of HLA-C using artificial
neural networks [23–25]. Only strong binders with half maxi-
mal inhibitory concentration less than 500 (6IC500) were
selected from the total epitopes generated.
Identification of ‘‘self” peptides
Each of the 9-mer peptides was analyzed for similarity with
any of the human proteins annotated so far. An indigenously
developed Perl script was applied to identify self-peptides
that exhibited: (1) 100% (9AA); (2) 90% (8AA); and (3) 70%
(7AA) similarity with the nonamer peptides of the human
proteome. The self-antigens were excluded from further
analysis.
Prediction of promiscuous epitopes and their antigenicity
Promiscuity means a given MHCmolecule can bind numerous
different peptides, and a peptide motif is recognized by differ-
ent MHC molecules. For BIMAS, epitopes that bound to three
or more alleles, and bound to five or more HLA alleles for
NetMHC, were selected as promiscuous epitopes. Vaxijen ser-
ver was used to predict the antigenicity of these promiscuous
peptides [26].The peptides that gave a score of 0.4 or above
were shortlisted and two top scorers for each protein were
used for docking studies.
Table 1 – Predicted peptide major histocompatibility complex binding profile of select DosR genes using BIMAS.
Protein Overlapping
nonamer
Total no. of
binding epitopes
Epitope
density
No. of alleles
bound
No. of promiscuous
epitopes
Rv2029 330 39 0.12 18 8
Rv2031 135 21 0.15 13 2
Rv2032 322 42 0.13 15 5
Rv2626 134 21 0.15 11 0
Rv2627 404 62 0.15 16 8
Rv2628 111 20 0.18 10 3
Rv2029 bound to the largest number and Rv2628 to the least number of alleles. A total of 26 promiscuous epitopes were found in all, but Rv2626
gave no promiscuous epitopes. Rv2628 has the maximum epitope density and Rv2029 has the lowest which is defined as the total number of
binding epitopes of a protein divided by the total number of nonamers generated.
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The binding of top scoring antigenic promiscuous peptides to
their respective class I alleles was investigated by docking.
Two MHC Class I alleles, A2 supertype (PDB-1S9Y) and B_5101
(PDB-1E27) were used to carry out docking because of their glo-
bal presence. Firstly, the docking was carried out by the CABS
dock server [27] and the linear peptide andMHCmoleculewere
separated from the docked structure. The linear peptide and
MHC molecule were than docked again using Hex to obtain
an energy score [28]. The control peptide was a cytotoxic
T lymphocyte CTL epitope (SLLMWITQS) belonging to NY-
ESO-1 testicular cancer antigen for A2 supertype allele. For
B_5101 allele, it was an immuno-dominant epitope (LPPVVA-
KEI) of human immunodeficiency virus. Different peptide-
MHC interactionswerevisualized usingDiscovery StudioVisu-
alizer version 4.1 (Accelerys Inc., San Diego, California, USA).Results
Physiological characterization of proteins
Using PsortB, it was found that three proteins (Rv2627,
Rv2628, and Rv2032) belonged to cytoplasm, whereas Rv2029
had an association with cytoplasmic membrane. Rv2031
was localized in the cell wall and location of Rv2626 could
not be predicted. By using the TMHMM and HMMTOP soft-
ware it was found that the proteins Rv2627 and Rv2029 pos-
sess two and one transmembrane helices respectively,
oriented to cytoplasmic side. None of the six proteins pos-
sessed a signal peptide sequence.
Total number of epitopes generated by BIMAS and NetMHC
A total of 1,436 overlapping nonamer peptides were generated
from six DosR proteins with a step size of one residue. Using
BIMAS, a total of 205 epitopes binding to 33 alleles were
selected with the described cutoff. Rv2627 gave the highest
number of MHC binding epitopes (62), followed by Rv2032
(42), and then Rv2029 (39).
NetMHC generated a total of 332 strong binding epitopes
for 78 alleles. Rv2627, again, gave the highest number of epi-
topes (95) binding to MHC class I, followed by Rv2032 (83)
and Rv2029 (48).Self-antigen determination
One self-peptide from Rv2031 ‘‘GRYEVRAEL” and Rv2032
‘‘EALLGCGAV”, and 24 peptides with 7 AA similarity were
removed from further analysis.
MHC class I binding profile of the DosR proteins
Specificity and promiscuity of peptide MHC class I allele binding
In BIMAS, 25 peptides bound to three alleles and only one epi-
tope (‘‘HPREQVTRL”) of Rv2627 bound to five alleles from six
DosR proteins. In NetMHC, 20 epitopes bound to five or more
alleles. The epitope ‘‘YIASLVASL” of Rv2627 bound to a
maximum of 13 alleles (Tables 1 and 2).
Epitope density of proteins
Epitope density is the ratio of number of MHC binding pep-
tides of a protein to the total number of overlapping non-
amers generated from that protein. Rv2628 was found to
have the highest epitope density and Rv2029 the lowest epi-
tope density in the software (Tables 1 and 2).
Proteins which bind to a large number of alleles
Rv2029 bound to a maximum of 18 alleles in BIMAS and 45
alleles in NetMHC, whereas Rv2628 bound to the lowest (10)
alleles in BIMAS and 29 alleles in NetMHC (Tables 1 and 2).
Alleles binding to maximum number of epitopes
In BIMAS, the allele B_2705 bound to maximum number of
nonameric peptides of the select DosR proteins followed by
B_5102, B_5101, and B_5103. The alleles A_1101, A_3101,
A_3302, B_3902, Cw_0602, and Cw_0702 did not bind to any
of the peptides (Fig. S1).
In NetMHC, allele A_0250, A_0211, A_0216, B_1503, B_2720,
B_3501, C_1203, and C_1402 showed maximum binding to the
epitopes. The alleles A_6601, B_0803, and B_4601 did not bind
to any epitope (Fig. S2).
Prediction of antigenicity of promiscuous epitopes
Only 25 of the 46 promiscuous epitopes from the six DosR pro-
teins gave a good Vaxijen score. Promiscuous epitope
‘‘SAFRPPLV”Rv2627 predicted by both the software gave the
highest Vaxijen score of 1.9157. Interestingly this predicted
Table 3 – Binding profile of two top VaxiJen scorer promiscuous antigens in BIMAS.
Protein Start position of
shortlisted peptides
Sequence Vaxijen score Alleles bound
Rv2029 265 DAMVAAITV 0.5216 B_5101, B_5102, B_5103
138 AAASAAFVV 0.5943 B_5101, B_5102, B_5103
Rv2032 75 AAAGTTANV 1.8645 B_5101, B_5102, B_5103
Rv2627 13 SAFRLSPPV 1.9157 B_5101, B_5102, B_5103
346 YAGIADRLV 1.2044 B_5101, B_5102, B_5103
Rv2628 106 YAIGEHLSV 1.1715 B_5101, B_5102, B_5103
64 TARVPGDEI 0.8211 B_5101, B_5102, B_5103
Rv2626 did not have any promiscuous epitopes and Rv2031 did not qualify for antigenicity; Rv2032 had only one antigenic epitope.
Table 4 – Binding Profile of Two Top VaxiJen Scorer Promiscuous Antigens In NetMHC.
Protein Start position of
shortlisted peptides
Sequence Vaxijen score Alleles bound
Rv2031 119 GILTVSVAV 0.6999 A_0206, A_0211, A_0212, A_0216, A_0206
Rv2032 209 VTFGRDFPV 1.5087 A_0201, A_0206, A_0211, A_0216, A_0250, A_3207, A_6802,
A_6823, B_1517, C_1203, C_1502
172 RLYDSSYHA 1.1400 A_0201, A_0202, A_0203, A_0206, A_0211, A_1212, A_0216,
A_0219, A_0250
Rv2626 61 GLDPNTATA 1.2741 A_0211, A_0212, A_0216, A_0219, A_0250
26 YMREHDIGA 1.2034 A_0203, A_0206, A_0211, A_0212, A_0206, A_0250
Rv2627 12 SAFRLSPPV 1.9157 A_0206, A_0211, A_0216, A_0250, A_6802, A_6901, B_2720, C_1203
285 GLACAILGV 0.7154 A_0201, A_0202, A_0203, A_0206, A_0211, A_0212, A_0216,
A_0219, A_0250
Rv2029 did not have any promiscuous epitopes and Rv2628 did not qualify for antigenicity; Rv2031 gave only one antigenic epitope.
Table 2 – Predicted peptide major histocompatibility complex binding profile of select DosR genes using NetMHC.
Protein Overlapping
nonamer
Total no. of
binding epitopes
Epitope
density
No. of alleles
bound
No. of promiscuous
epitopes
Rv2029 330 48 0.14 45 0
Rv2031 135 34 0.25 33 3
Rv2032 322 83 0.26 44 6
Rv2626 134 36 0.26 29 4
Rv2627 404 95 0.23 44 6
Rv2628 111 36 0.32 29 1
Rv2029 bound to the maximum alleles but did not generate any promiscuous epitope. Rv2628 bound to the least number of alleles but still gave
one promiscuous epitope. Rv2628 has the maximum epitope density and Rv2029 has the least epitope density in NetMHC.
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that is, A, B, and C (Tables 3 and 4).
Docking of promiscuous epitopes to globally relevant alleles
Seven epitopes for A2 supertype and seven epitopes for
B_5101were docked and their energy scores were found com-
parable to that of the control peptide. For A2 supertype, epi-
tope ‘‘VTFGRDFPV” gave the maximum energy. The anchor
residues at position second and ninth were found to have sig-
nificant hydrophobic interactions with MHC molecule. Other
relevant interactions are also depicted in Fig. 1A and
Tables 5 and 6.
For allele B_5101, the epitope ‘‘DAMVAAITV” of Rv2029
gave maximum binding energy which can be attributed to
the four hydrogen bonds formed by the peptide at positionAsp1, Met3, Ala5, and Thr8, with Asn77, Asn70, Tyr99,
Glu55, and Val34 of the MHC respectively (Fig. 1B, Tables 3
and 4). The epitopes have hydrophobic AA at the second
and ninth position as these residues help in anchoring the
peptide into the MHC groove as shown in Fig. 2A and B.
Discussion
There is increasing experimental evidence to support that
CD8+ T cells provide immunity by releasing the proinflamma-
tory cytokines and lysing Mtb infected cells. To activate CD8+
T cells, mycobacterial antigens need to enter the class I MHC
pathway before they can be processed and presented by class
I MHC on the cell surface. In spite of having support for the
role of CD8+ cells in protective immunity, very few CTL epi-
topes of Mtb are known. It was shown by Andersen [29] that
Fig. 1 – Two different class I MHC molecules with nonameric peptides and their anchor residues (Green) Anchor residues, at
positions 2 and 9, that interact with the class I MHCmolecule tend to be hydrophobic amino acids. The twoMHC proteins bind
peptideswith different anchor residues. Contactwith theMHCmolecule is by hydrogen bonds to anchor residues 2 and 9.Note.
Ala = alanine; Arg = arginine; Asp = aspartic acid; Cys = cysteine; Gly = glycine; His = histidine; Ile = isoleucine; Leu = leucine;
Lys = lysine; Met = methionine; MHC =major histocompatibility complex; Phe = phenylalanine; Pro = proline; Ser = serine;
Trp = tryptophan; Tyr = tyrosine; Val = valine.
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infection and this could have implications for the develop-
ment of postexposure vaccines against latent TB [29].
Recently, some TB vaccines are beingmade by incorporating
the late phase DosR regulon latency antigens as a strategy to
improve the efficacyof BCG. ID93 andH56-IC31 are twovaccines
currentlyunderdifferent stagesof trialwhichhave incorporated
DosR antigens, Rv1813c and Rv2660, respectively [3]. The DosR
regulonhassome50genesunder itandexamining theantigenic
potential of each protein experimentally is an expensive and
tedious process. Therefore, an initial computational filtration
of probable CTL candidate antigens would be cost and time
effective. Reverse immunology based on bioinformatics tools
to predict relevant epitopes, followed by in vitro/ex vivo valida-
tion of selected epitopes would be a better solution.
Humans possess three HLA gene loci A, B, and C, which are
highly polymorphic andare codominantly expressed [11].MHC
class I is restricted by epitopes which are 8–10 AA long. Non-
amers have higher binding affinity for MHC class I in compar-
ison to longer or shorter peptides [11]. Thus, in our study the
length of the peptide was kept to nine AAs. Most of our MHC
class I epitopes had hydrophobic AAs at the second and ninth
position as these residues help in anchoring the peptide into
the MHC groove. The second, third, fifth, and ninth residues
of the peptides interacted with the MHC molecules, whereas
the remaining residues may interact with T-cell receptors
which corroborates with the previous findings [11].
None of the six proteins were found to be secretory in nat-
ure; two proteins, Rv2627 and Rv2029, had transmembranedomains but were located on the cytoplasmic side, whereas
the remaining four proteins were located in the cell
cytoplasm. Previously, only secretory proteins were consid-
ered to be antigenic; however, nonsecretory or somatic pro-
teins can be processed by MHC class I machinery and
presented to CD8+ T cells [30].
NetMHC server distinguishes between strong and weak
binding epitopes. There is a clear bias towards HLA-A binders
in this server with 413 strong binding epitopes, whereas
HLA-B or HLA-C allele bound to 245 and 87 epitopes, respec-
tively. For BIMAS, the affinity with which a peptide bound to
an allele was in the range of 100–6000 minutes and 53 epi-
topes had T1/2 of 500 min or more. In our study, we found that
BIMAS gave a higher number of epitopes binding to B allele
and that was with stronger binding affinity in comparison
to other loci. It has been reported that HLA-B-restricted epi-
topes elicit stronger CD8+ T-cell response in Mtb infection,
as well as in many viral infections [5,14,31,32,6].
The self-peptides found in our DosR proteins shared
homology with polycystin-1 isoform X8 and mitogen-
activated protein kinase kinase kinase 9 isoform X3 respec-
tively. These self-peptides are poor binders to their cognate
class I molecule as the number of T cells that might recognize
them will be diminished due to their thymic and peripheral
deletion [33]. They might also mount an autoimmune
response on recognition [11,15].
It was observed that BIMAS had 17 alleles, whereas
NetMHC had 33 alleles which are predominant in North
Indian populations. Five alleles in HLA-A, five in HLA-B, and
Table 5 – Docking of promiscuous antigenic peptides with A2 supertype (1S9Y).
Protein Sequence Hex energy
score
Peptide-MHC hydrogen bond Peptide-MHC hydrophobic interactions Peptide-MHC electrostatic
interactions
Rv2031 GILTVSVAV –519.26 Gly 1-Glu 55, Phe 33; Thr 4-Tyr 99, Lys 66, Val
34
Ile 2-Met 5, Phe 33; Leu 3-Lys 66, Tyr 7; Val 5-
Tyr 159; Val 7-Trp 147, Val 152
None found
Rv2032 VTFGRDFPV –641.43 Thr 2-Cys 164, Met 5; Arg 5-Arg 97; Asp 6-His
70;
Val 1-Tyr 7, Val 34, Phe 33; Phe 3-Val 67, Ala
24, Tyr 7; Arg 5-Tyr 99, Leu 160, Tyr 159, Leu
156; Phe 7-Leu 156, Trp 133, Ile 124, Tyr 116;
Val 9-Val 152
Val 1-Glu 63; Phe 3-Arg 97; Asp 6-Arg
97
RLYDSSYHA –598.92 Leu 2-His 70; Tyr 3-Arg 97; His 8-Tyr 59 Leu 2-Ala 69; Tyr 7- Val 67, Tyr 7, Ala 24; His
8-Met 45, Ile 52, Val 34; Ala 9-Met 5
Arg 1-Asp 77; Asp 4-Tyr 159, Lys 66;
His 8-Glu 63; Ala 9-Phe 33
Rv2626 GLDPNTATA –455.61 Pro 4-Tyr 159; Thr 8-Asp 77 Lys 2-Phe 33, Tyr 59, Trp 167; Pro 4-Tyr 159;
Ala 9-His 114, Leu 156, Val 152,
Ala 9-Trp 147, Arg 97
YMREHDIGA –608.91 Tyr 1-Trp 167; His 5-His 70; Asp 6-His 70; Ile
7-His 114; Gly 8-Arg 97; Ala 9-Thr 143
Met 2-His 70; Arg 3-Tyr 159; His 5-His 70, His
114; Ile 7-Trp 133, Ile 124, His 114
Tyr 1-Trp 167; Asp 6-Arg 97; Ala 9- yr
116
Rv2627 SAFRLSPPV –589.00 Ser 1-Tyr 171; Arg4-Tyr 113, Tyr 159; Ser 6-
Gln 155; Pro 8-Tyr 99, Arg 97; Val 9-Thr 143
Ala 2-Met 5, His 70; Phe 3-Tyr 7, His 70; Arg
4-Cys 164, Tyr 99; Lys 5-Lys 66; Pro 7-His 70;
Pro 8-Trp 133, His 114
Ser 1-Glu 63; Val 9-Tyr 116
GLACAILGV –550.01 Gly 1-His114; Ala 5-Arg 97; Ile 6-Lys 66; Gly
8-Glu 63
Ala 3-His 114, His 70, His 74; Cys 4-Leu 156;
Ala 5-His 70; Ile 6-Cys 164, Met 5; Leu 7-Vl
67, Lys 66; Val 9-Trp 167, Leu 168, Phe 33
Gly 1-His 114; Val 9-Phe 33
The straightened peptide and the MHC obtained from CABS dock server were docked on to Hex. The energy score of the docked structure was compared to the control peptide. Control energy for A2
supertype is 560.06. The epitope of Rv2032 gave the highest energy score. Different interactions occurring between the ligand and MHC are also shown.
Note. Ala = alanine; Arg = arginine; Asp = aspartic acid; Cys = cysteine; Gly = glycine; His = histidine; Ile = isoleucine; Leu = leucine; Lys = lysine; Met = methionine; MHC = major histocompatibility
complex; Phe = phenylalanine; Pro = proline; Ser = serine; Trp = tryptophan; Tyr = tyrosine; Val = valine.
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Table 6 – Docking of promiscuous antigenic peptides with B_5101 (1E27).
Protein Sequence Hex energy
score
Peptide-MHC hydrogen bond Peptide-MHC hydrophobic interactions Peptide-MHC electrostatic
interactions
Rv2029 DAMVAAITV –532.85 Asp 1-Asn 77; Met 3-Asn 70; Ala 5-
Tyr 99; Thr 8-Glu 55, Val 34
Met 3-Leu 156; Val 4-Tyr 99,Tyr 7; Ala 5-Ile 66,
Tyr 7; Ala 6-Leu 163, Tyr 159; Ile 7-Val 34; Val 9-
His 171, Met 5
Asp 1-Glu 152, Lys 146; Val 9-Phe 33,
His 171
AAASAAFVV –491.00 Ala 2-Asn 77; Ser 4-Asn 77, Tyr 9, Asn
70
Ala 1-Lys 146; Ala 2-Ile 80; Ala 3-Trp 147, Tyr
116; Ala 5-Trp 147, Tyr 116; Ala 6-Tyr 9, Tyr 7;
Phe 7-Cys 164, Leu 163, Tyr 159; Val 8-Arg 62, Ile
66, Trp 167; Val 9-Val 34, Phe 36, Tyr 7
Rv2032 AAAGTTANV –476.00 Ala 1-Asn 114; Ala 2-Thr 73; Asn 8-
Leu 163; Val 9-Arg 62
Ala 1-Tyr 116, Trp 95; Ala 2-Trp 95; Ala 3-Phe 22,
Tyr 9, Tyr 7; Thr 6-Tyr 99; Ala 7-Phe 67, Ile 66; Val
9-Leu 163
Val 9-Arg 62
Rv2627 SAFRLSPPV –485.16 Ser 1-Arg 62; Ala 2-Asn 63; Arg 4-Leu
156; Pro 7-Trp 147
Ala 2-Trp 167, Tyr 59; Phe 3-Ile 66, Phe 67;Arg 4-
Tyr 159, Tyr7; Leu 5-Ile 66; Pro 7-Tyr 116; Pro 8-
Trp 95, Tyr 9
Phe 3-Tyr 159
YAGIADRLV –503.75 Tyr 1-Asn 63; Gly 3-Ile 66; Asp 6-Tyr
9, Tyr 116
Tyr 1-Tyr 7; Ala 2-Trp 167; Ile 4-Cys 164, Tyr 99;
Val 9-Trp 147, Leu 156
Arg 7-Glu 152
Rv2628 YAIGEHLSV –471.07 Ala 2-Asn 77; E 5-Thr 143; Leu 7-Asn
114; Ser 8-Asn 114
Ile 3-Ala 150, Lys 146; Leu 7-Leu 156;Ser 8-Tyr 99;
Val 9-Leu 156, Tyr 99, Tyr 149
Glu 5-Tyr 116, Val 9-Tyr 7
TARVPGDEI –454.89 Val 4-Asn 70; Pro 5-Thr 73; Gly 6-Asp
77; E 8-Thr 143
Ala 2-Arg 62, Tyr 59; Arg 3- le 66, Pro 380; Val 4-
Tyr 7; Asp 7-Trp 147
Arg 3-Tyr 159; Asp 7-Trp 147
The straightened peptide and the MHC obtained from CABS dock server were docked on to Hex. The energy score of the docked structure was compared to the control peptide. Control energy for
B_5101 is 512.00. The epitope of Rv2029 gave the highest energy score. Different interactions occurring between the ligand and MHC are also shown.
Note. Ala = alanine; Arg = arginine; Asp = aspartic acid; Cys = cysteine; Gly = glycine; His = histidine; Ile = isoleucine; Leu = leucine; Lys = lysine; Met = methionine; MHC = major histocompatibility
complex; Phe = phenylalanine; Pro = proline; Ser = serine; Trp = tryptophan; Tyr = tyrosine; Val = valine.
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ware. The alleles which bound to a large number of epitopes
were A_0211, A_6801, A_0206, C_1203, A_3101, and B_3501
and their frequency coverage ranged from 3.3% to 22.2% in
North India. This information is important as India shares
24% of global TB burden according to a World Health Organi-
zation report [34].
For a good vaccine design, promiscuous epitopes are of
greater significance as they have broad specificity in terms
of HLA binding. Only 12.8% in BIMAS and 6.3% in NetMHC
were promiscuous epitopes out of which 54% were antigenic
in nature, making them important in the vaccine develop-
ment process. Fourteen top scoring antigenic epitopes were
docked with either HLA-A2 allele, having a global frequency
of 80% and almost 40% frequency in North India, or B_5101
allele, which strongly bound to majority of the epitopes.
[6,35–39]. The energy score of the docked structures was
not only comparable to the cocrystallized control epitopes
of the two referred alleles but also to the previously
reported Mtb secretory epitopes, ‘‘YMLDMTFPV” of Rv3036
and ‘‘LGKAMTNLL” of Rv3812, which bound to alleles
A_0201 and B_5101, respectively.
MHC class I alleles have six pockets from A–F, each of
which has residues which are either conserved or polymor-
phic and play an essential role in peptide MHC interactions
[33]. It is reported that specificity for class I binding is largely
conferred by two or three dominant anchor residues, while
antigen specificity of MHC-peptide complex recognition is
generally determined by the few side chains of the peptide
antigen that are solvent-exposed (between one and three resi-
dues) and available for T-cell receptor contacts [40]. All our
docked epitopes of A2 allele interacted with the different resi-
dues found in the six pockets. Residues at second and ninth
positions of the epitopes are hydrophobic which facilitates
the peptide’s interaction with the pocket B and F of the
MHC allele, respectively. As reported in literature, all our epi-
topes binding to B_5101 were also found to have alanine at the
second position and valine or isoleucine at the ninth position.
It is the hydrogen-bonding which secures the peptide’s N-
terminus and C-terminus independent of peptide sequence. It
also serves as a bridge between the peptide and buried hydro-
philic MHC residues [41]. Hydrophobic interactions between
MHC and peptide are the driving force for the specific binding,
whereas charged residues form strong electrostatic interac-
tions which are essential in strengthening the peptide MHC
interactions [41]. We observed that the interactions between
the epitope and the allele were similar in both CABS dock ser-
ver and Hex programs. This further substantiates the candi-
dature of selected epitopes for incorporation in future
vaccines.3
Fig. 2 – Docking of peptides with globally relevant alleles. A) Ball
the A2 Supertype (1S9Y). The inset shows the detailed interacti
Potential bonds formed between the two are shown as broken
Hydrophobic). Second residue is Threonine and last residue is Va
docked onto the B_5101 (1E27). The inset shows the detailed in
Potential bonds formed between the two are shown as broken
Hydrophobic). Second residue is Alanine and last residue is VaWe have tested the immunogenicity of these six proteins
and found it was Rv2627 which elicited maximum CD8
response (unpublished data). This bioinformatics study sup-
ports the same and provides us with promiscuous and anti-
genic epitopes of not just Rv2627 but the other five proteins
which are expressed during latent TB capable of binding to
MHC class I with high affinity. These epitopes can become
part of a postexposure multivalent subunit vaccine upon
experimental validation. The antigenicity of these peptides
is currently being tested experimentally in our laboratory
using peptide microarray and MHC tetramer technology.
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